Showing results (1161-1170 of 1,562) with videos related to
Sort By:
Pageof 157
Nature Genetics|November 18, 2014
Emergence of scarlet fever Streptococcus pyogenes emm12 clones in Hong Kong is associated with toxin acquisition and multidrug resistanceMark R Davies, Matthew T Holden, Paul Coupland, et al.Communications Biology|December 5, 2019
Genetic variation associated with infection and the environment in the accidental pathogen Burkholderia pseudomalleiClaire Chewapreecha, Alison E Mather, Simon R Harris, et al.Nature Microbiology|August 20, 2021
Identification of Tse8 as a Type VI secretion system toxin from Pseudomonas aeruginosa that targets the bacterial transamidosome to inhibit protein synthesis in prey cellsLaura M Nolan, Amy K Cain, Thomas Clamens, et al.Plos Neglected Tropical Diseases|June 13, 2015
Oral Wild-Type Salmonella Typhi Challenge Induces Activation of Circulating Monocytes and Dendritic Cells in Individuals Who Develop Typhoid DiseaseFranklin R Toapanta, Paula J Bernal, Stephanie Fresnay, et al.Plos One|January 8, 2016
Differential Killing of Salmonella enterica Serovar Typhi by Antibodies Targeting Vi and Lipopolysaccharide O:9 AntigenPeter J Hart, Colette M O'Shaughnessy, Matthew K Siggins, et al.BMC Cancer|May 6, 2018
Metabolomic profiles in breast cancer:a pilot case-control study in the breast cancer family registryMarcelle M Dougan, Yuqing Li, Lisa W Chu, et al.Clinical and Experimental Rheumatology|January 5, 2026
Clinical phenotypes and long-term outcomes of anti-SRP versus anti-HMGCR immune-mediated necrotising myopathy: a 13-year single-centre studyKristina E N Clark, Lisa M Clayton, Rhys G Thomas, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 29, 2020
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune checkpoint inhibitor endocrinopathies and the role of advanced practice providers in the management of immune-mediated toxicitiesTim Cooksley, Monica Girotra, Pamela Ginex, et al.Journal of Medicinal Chemistry|August 27, 2021
Discovery of the Bruton's Tyrosine Kinase Inhibitor Clinical Candidate TAK-020 (S)-5-(1-((1-Acryloylpyrrolidin-3-yl)oxy)isoquinolin-3-yl)-2,4-dihydro-3H-1,2,4-triazol-3-one, by Fragment-Based Drug DesignMark Sabat, Douglas R Dougan, Beverly Knight, et al.Vaccine|June 2, 1998
Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvantM Marchetti, M Rossi, V Giannelli, et al.Pageof 157